After in vitro treatment of MH-22A cells with APG-115, expression of p53 and p-STAT3 proteins were upregulated in a dose-dependent manner, indicating activation of p53 and STAT3 signaling pathway in these tumor cells (Fig. 3a). The gene discussed is TP53; the disease is neoplasm.